iRhythm Holdings (IRTC) EBT Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -18.50% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 11.26% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -8.83% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 44.35% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 5.78% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 103.34% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 74.66% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -27.02% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 54.33% |
| 10 | iRhythm Holdings | 3.55 Bn | 3.00 Bn | 141.35 Mn | 55.28% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 55.28% |
| Dec 31, 2025 | 609.81% |
| Sep 30, 2025 | 88.72% |
| Jun 30, 2025 | 27.68% |
| Mar 31, 2025 | 34.18% |
| Dec 31, 2024 | 96.93% |
| Sep 30, 2024 | -70.85% |
| Jun 30, 2024 | -9.00% |
| Mar 31, 2024 | -16.95% |
| Dec 31, 2023 | -91.03% |
| Sep 30, 2023 | -26.18% |
| Jun 30, 2023 | 23.45% |
| Mar 31, 2023 | 22.82% |
| Dec 31, 2022 | 37.95% |
| Sep 30, 2022 | 9.74% |
| Jun 30, 2022 | -38.39% |
| Mar 31, 2022 | -82.66% |
| Dec 31, 2021 | -235.21% |
| Sep 30, 2021 | -416.99% |
| Jun 30, 2021 | 15.08% |
| Mar 31, 2021 | -205.94% |
| Dec 31, 2020 | 44.02% |
| Sep 30, 2020 | 74.98% |
| Jun 30, 2020 | -89.60% |
| Mar 31, 2020 | -9.83% |
| Dec 31, 2019 | -6.51% |
| Sep 30, 2019 | -87.86% |
| Jun 30, 2019 | 12.26% |
| Mar 31, 2019 | 25.90% |
| Dec 31, 2018 | -37.44% |
| Sep 30, 2018 | -42.10% |
| Jun 30, 2018 | -80.56% |
| Mar 31, 2018 | -99.69% |
| Dec 31, 2017 | -126.69% |
| Sep 30, 2017 | -97.09% |
| Jun 30, 2017 | -50.22% |
| Mar 31, 2017 | 1.75% |
| Dec 31, 2016 | 30.34% |
| Sep 30, 2016 | 39.30% |